Skip to main content
Premium Trial:

Request an Annual Quote

IDbyDNA Raises $20M in Series B Financing

NEW YORK – Metagenomics technology company IDbyDNA announced Wednesday it has raised $20 million in a Series B financing round. Artis Ventures led the round, joined by Genesys Capital and other investors.

The firm said in a statement it will use the funds to enhance and expand its Explify software platform and to support the opening of a CLIA-approved commercial laboratory.

The University of Utah spinout is based in San Francisco with a lab in Salt Lake City, Utah. Its Explify next-generation sequencing-based diagnostics platform identifies more than 50,000 microorganisms — including more than 3,000 pathogens. It can also quantify and detect antimicrobial resistance, the firm said.

"We believe IDbyDNA's technology has hit a tipping point and is now set to revolutionize the way we respond to, and tackle, infectious disease outbreaks, and address the growing concerns of antimicrobial resistance," Stuart Peterson, partner at Artis Ventures, said in a statement. Artis Ventures also led IDbyDNA's $9 million Series A funding round.

In 2018, IDbyDNA licensed Explify to Brazil-based Fleury Group and partnered with Rady Children's Institute for Genomic Medicine on a clinical trial using Explify to diagnose central nervous system infections in pediatric patients.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.